Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck

Japan’s Shionogi has started human trials for a once-a-day drug designed to neutralize the coronavirus in less than a week as Pfizer and Merck carry out later-stage tests.

The Wall Street Journal | I+D | Salud |

Leer noticia completa en el medio original
Spanish